Net Cash Provided by (Used in) Financing Activities of Humacyte, Inc. from 30 Sep 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Humacyte, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2020 to 31 Mar 2025.
  • Humacyte, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $46,739,000, a 26% decline year-over-year.
  • Humacyte, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $114,183,000, a 2433% increase from 2023.
  • Humacyte, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,507,000.
  • Humacyte, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,446,000, a 101% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Humacyte, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $46,739,000 -$16,056,000 -26% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $62,795,000 +$63,204,000 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $409,000 +$52,000 +11% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $461,000 -$19,732,000 -102% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $19,271,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q3 2020 $101,334,363 01 Jul 2020 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3

Humacyte, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $114,183,000 +$109,676,000 +2433% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $4,507,000 +$5,953,000 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $1,446,000 -$268,429,000 -101% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $266,983,000 +$264,931,000 +12911% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $2,052,000 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.